Can omeprazole be administered to a 14-year-old child for acid suppression?

Yes, omeprazole can be given to a 14-year-old child.

Omeprazole is FDA-approved for use in children aged 2 to 16 years for the treatment of symptomatic GERD, erosive esophagitis, and maintenance of healing of erosive esophagitis 1. A 14-year-old falls squarely within this approved age range.

FDA-Approved Indications and Dosing

According to the FDA drug label and American Academy of Pediatrics guidelines, omeprazole is indicated for children 2-16 years old at doses of 0.7-3.3 mg/kg/day 2. The medication can be administered by:

• Sprinkling capsule contents onto soft foods (applesauce)
• Taking the capsule whole if the child can swallow it

Clinical Evidence Supporting Use

The evidence base for omeprazole in this age group is robust:

• Efficacy: Open-label studies demonstrated that omeprazole at 0.7-3.3 mg/kg daily effectively healed erosive esophagitis in children aged 1-16 years, with 54 of 57 patients (95%) achieving healing 3. The most common effective dose was 0.7 mg/kg/day (44% of patients) or 1.4 mg/kg/day (28% of patients) 2.

• Safety profile: Omeprazole is considered safe and generally well-tolerated in children with relatively few adverse effects 2. Studies have reported PPI use for up to 11 years in small numbers of children 2.

• Pharmacokinetics: The pharmacokinetic parameters in children aged 2-16 years are comparable to adults, with similar half-life values (0.7-1.4 hours) 4. However, children require higher per-kilogram doses than adults due to increased metabolic capacity, particularly in younger children 5.

Important Caveats and Monitoring

While omeprazole is approved and effective, several cautions apply:

• Appropriate indication required: The AAP guidelines emphasize concern about overprescription of PPIs, particularly in infants 2. Ensure the 14-year-old has a legitimate indication (documented GERD, erosive esophagitis, or peptic ulcer disease) rather than simple physiologic reflux.

• Potential adverse effects to monitor include:

  • Headaches, diarrhea, constipation, nausea (up to 14% of older children) 2
  • Increased risk of community-acquired pneumonia, gastroenteritis, and candidemia with acid suppression 2, 6
  • Bone fractures with long-term use (>1 year) 1
  • Kidney problems (tubulointerstitial nephritis, acute kidney injury) 1, 7
  • Hypomagnesemia with prolonged use 1

• Dosing timing matters: Administer approximately 30 minutes before meals for optimal effectiveness 6. The timing of PPI dosing significantly impacts efficacy.

• Duration considerations: While FDA-approved for up to 12 months for maintenance therapy, use the lowest effective dose for the shortest duration necessary 1.

Practical Prescribing Approach

For a 14-year-old with documented GERD or erosive esophagitis:

1. Start with 0.7-1.4 mg/kg/day (typically translating to 20-40 mg daily for most adolescents)
2. Administer once daily, 30 minutes before breakfast
3. Reassess after 4-8 weeks for symptom improvement and consider endoscopy if treating erosive esophagitis
4. If inadequate response, consider increasing to 1.4 mg/kg/day or switching to twice-daily dosing (which shows superior efficacy in some studies) 8
5. Once symptoms controlled, attempt to wean to the lowest effective dose or discontinue if possible

The evidence strongly supports omeprazole use in 14-year-olds when clinically indicated, with the caveat that appropriate diagnosis and monitoring are essential to avoid unnecessary long-term PPI exposure.